These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20190285)

  • 1. Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes.
    Sathyapalan T; Manuchehri AM; Rigby AS; Atkin SL
    Diabetes Care; 2010 Mar; 33(3):e37. PubMed ID: 20190285
    [No Abstract]   [Full Text] [Related]  

  • 2. Subclinical hypothyroidism and mortality in women with type 2 diabetes.
    Chubb SA; Davis WA; Davis TM
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):476-7. PubMed ID: 16584526
    [No Abstract]   [Full Text] [Related]  

  • 3. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Subclinical thyroid dysfunction and mortality in type 2 diabetes.
    Badshah I; Chubb SAP; Davis WA; Davis TME
    J Diabetes Complications; 2017 Sep; 31(9):1474. PubMed ID: 28645682
    [No Abstract]   [Full Text] [Related]  

  • 5. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in type 2 diabetes.
    Reunanen A
    Ann Clin Res; 1983; 15 Suppl 37():26-8. PubMed ID: 6679186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies.
    Schernthaner G
    Wien Klin Wochenschr; 1999 Jan; 111(2):43-5. PubMed ID: 10081120
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality experience of Navajos with type 2 diabetes mellitus.
    O'Connor PJ; Crabtree BF; Nakamura RM
    Ethn Health; 1997 Aug; 2(3):155-62. PubMed ID: 9426980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan.
    Radaideh AR; Nusier MK; Amari FL; Bateiha AE; El-Khateeb MS; Naser AS; Ajlouni KM
    Saudi Med J; 2004 Aug; 25(8):1046-50. PubMed ID: 15322596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of diabetes on death certificates of 1872 people with type 2 diabetes in Tayside, Scotland.
    Evans JM; Barnett KN; McMurdo ME; Morris AD
    Eur J Public Health; 2008 Apr; 18(2):201-3. PubMed ID: 18160393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
    Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
    Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
    Tkác I
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.
    Dinneen SF; Gerstein HC
    Arch Intern Med; 1997 Jul; 157(13):1413-8. PubMed ID: 9224218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular consequences of thyroid diseases, their prevalence and treatment, particularly in cases with subclinical hyper- and hypothyroidism].
    Molnár I
    Orv Hetil; 2005 Oct; 146(40):2067-72. PubMed ID: 16259335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study.
    Doney AS; Lee S; Leese GP; Morris AD; Palmer CN
    Circulation; 2005 Jun; 111(22):2927-34. PubMed ID: 15927971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.
    Kervinen M; Lehto S; Ikäheimo R; Karhapää P; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2010 Mar; 25(3):892-6. PubMed ID: 19846391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.